Table 2.
Results for direct pairwise comparisons and network meta-analysis.
| A. Gestational Diabetes Mellitus | |||||
|---|---|---|---|---|---|
| Control | Aerobic | Combined | Resistance | Metformin | |
| Control | 0.59 * (0.41, 0.85) |
0.91 (0.67, 1.22) |
0.78 (0.59, 1.02) |
||
| Aerobic | 0.51 * (0.26, 0.97) |
- | - | ||
| Combined | 0.75 (0.47, 1.19) |
1.49 (0.65, 3.43) |
- | ||
| Resistance | |||||
| Metformin | 0.74 (0.49, 1.10) |
1.46 (0.63, 3.37) |
0.98 (0.54, 1.77) |
||
| B. Hypertensive disorders of pregnancy | |||||
| Control | 0.95 (0.56, 1.62) |
0.65 (0.36, 1.14) |
0.48 (0.19, 1.22) |
||
| Aerobic | 1.19 (0.36, 3.89) |
- | - | ||
| Combined | 0.64 (0.26, 1.57) |
0.54 (0.12, 2.38) |
- | ||
| Resistance | |||||
| Metformin | 0.47 (0.22, 1.04) |
0.40 (0.09, 1.69) |
0.74 (0.22, 2.44) |
||
| C. Maternal weight gain | |||||
| Control | −1.91 * (−2.74, −1.07) |
−0.31 (−1.06, 0.44) |
−1.35 (−3.57, 0.88) |
−2.82 (−7.26, 1.62) |
|
| Aerobic | −1.40 (−3.47, 0.68) |
- | - | - | |
| Combined | −0.24 (−1.68, 1.20) |
1.15 (−1.37, 3.68) |
- | - | |
| Resistance | −1.35 (−4.29, 1.59) |
0.05 (−3.55, 3.65) |
−1.10 (−4.38, 2.17) |
- | |
| Metformin | −2.93 * (−4.98, −0.87) |
−1.53 (−4.44, 1.38) |
−2.68 * (−5.19, −0.17) |
−1.58 (−5.17, 2.01) |
|
Light gray indicates lack of direct and indirect comparisons. Dark gray separates direct from indirect comparisons. Gestational diabetes mellitus and hypertensive disorders of pregnancy were measured as risk ratio (95% CI). Maternal weight gain was measured as mean difference (95% CI). Upper diagonal: Standard meta-analysis. Lower diagonal: Network meta-analysis estimates. * Statistical significance.